Literature DB >> 34346306

COVID-19 in South Korea: Proper timing for Easing Mask mandates after COVID-19 Vaccination.

Yun-Jung Kang1.   

Abstract

As of 25 July 2021, the Korea Disease Control and Prevention Agency reported 1,422 new COVID-19 cases, 188,848 total cases, and 2.073 total deaths (1.10% fatality rates). Since the first SARS-CoV-2 case was reported, efforts to find a treatment and vaccine against COVID-19 have been widespread. Four vaccines are on the WHO's emergency use listing and are approved of their usage; BNT162b2, mRNA-1273, AZD1222, and Ad26.COV2.S. Vaccines against SARS-CoV-2 need at least 14 days to achieve effectiveness. Thus, people should abide by prevention and control measures, including wearing masks, washing hands, and social distancing. However, a lot of new cases were reported after vaccinations, as many people did not follow the prevention control measures before the end of the 14 days period. There is no doubt we need to break free from mask mandates. But let us not decide the timing in haste. Even if the mask mandates are eased, they should be changed depending on the number of reported cases, vaccinations, as well as prevention and control measures on how circumstances are changing under the influence of mutant coronavirus.

Entities:  

Keywords:  Breakthrough infection; COVID-19; Mask; SARS-CoV-2; Vaccination

Year:  2021        PMID: 34346306     DOI: 10.1017/dmp.2021.258

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  2 in total

1.  Omicron: The pandemic propagator and lockdown instigator - what can be learnt from South Africa and such discoveries in future.

Authors:  Indrajit Banerjee; Jared Robinson; Indraneel Banerjee; Brijesh Sathian
Journal:  Nepal J Epidemiol       Date:  2021-12-31

2.  A Data-driven, Dynamic and Flexible Approach to Safely Lifting Mask Mandate: A Proposal.

Authors:  Cynthia Chen; Shiqian Shen
Journal:  Explor Res Hypothesis Med       Date:  2022-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.